4.7 Article

Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma

Angela Corvino et al.

Summary: The study focuses on the design and synthesis of molecular hybrids capable of releasing hydrogen sulfide, with the Prednisone-TBZ hybrid showing promising anti-inflammatory properties in reducing allergic asthma symptoms and exacerbations.

JOURNAL OF ADVANCED RESEARCH (2022)

Article Chemistry, Medicinal

Cardiovascular benefits of Eruca sativa mill. Defatted seed meal extract: Potential role of hydrogen sulfide

Lara Testai et al.

Summary: This study demonstrates that Eruca sativa DSM extract has beneficial nutraceutical properties on the cardiovascular system, mainly attributed to its ability to release H2S.

PHYTOTHERAPY RESEARCH (2022)

Review Chemistry, Multidisciplinary

Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies

Susmit Mhatre et al.

Summary: Glaucoma is a common cause of blindness worldwide, characterized by progressive degeneration of the retinal ganglion cells. Current treatments focus on reducing intraocular pressure, but an ideal treatment should also offer neuroprotection and regeneration of retinal ganglion cells. Hydrogen sulfide, a gasotransmitter, shows potential therapeutic applications in glaucoma by increasing aqueous humor outflow and providing neuroprotection. However, its delivery to different parts of the eye is challenging due to its unique physicochemical properties.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Multidisciplinary Sciences

Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent

Valentina Citi et al.

Summary: A study evaluated the hydrogen sulfide releasing capacity of forty-five isothiocyanates, with 3-pyridyl-isothiocyanate (25) showing promising results. Compound 25 exhibited positive effects in cardioprotection and could be a suitable option for anti-ischemic therapy.

JOURNAL OF ADVANCED RESEARCH (2021)

Review Pharmacology & Pharmacy

Protecting the aging eye with hydrogen sulfide

Akash K. George et al.

Summary: Senescence is closely associated with tissue dysfunction and can lead to various eye diseases. Understanding the role of hydrogen sulfide (H2S) as an antioxidant in treating eye diseases and researching its effects may provide new therapeutic strategies for eye diseases.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells

Flavia Giordano et al.

Summary: The newly synthesized hybrids with H2S-donor moieties have shown promise in treating asthma by enhancing drug efficacy and reducing toxicity. These compounds modulate multiple targets and release H2S, resulting in inhibiting cell degranulation and inducing cell membrane hyperpolarization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Trends in H2S-Donors Chemistry and Their Effects in Cardiovascular Diseases

Angela Corvino et al.

Summary: Hydrogen sulfide (H2S) is an endogenous gasotransmitter that has emerged as an important regulatory mediator in numerous human cell functions. It plays a significant role in various physio-pathological processes and the protective effects of H2S donors have been extensively studied in different disease models. The growing interest in H2S-releasing compounds highlights their potential as promising drugs for the treatment of cardiovascular diseases.

ANTIOXIDANTS (2021)

Article Medicine, General & Internal

Glaucoma

Jessica Minjy Kang et al.

MEDICAL CLINICS OF NORTH AMERICA (2021)

Review Biochemistry & Molecular Biology

Hydrogen Sulfide: Novel Endogenous and Exogenous Modulator of Oxidative Stress in Retinal Degeneration Diseases

Panpan Li et al.

Summary: The article reviews the oxidative stress responses and regulatory mechanisms of H2S and its donors as endogenous and exogenous regulators in retinal degenerative diseases, suggesting that understanding these mechanisms may help identify the therapeutic potential of H2S in treating retinal degenerative diseases.

MOLECULES (2021)

Review Biochemistry & Molecular Biology

The Role of Hydrogen Sulfide in Respiratory Diseases

Saadullah Khattak et al.

Summary: Hydrogen sulfide has been widely investigated for its therapeutic potential in respiratory diseases such as obstructive respiratory disease and bronchial asthma. Despite extensive research, a concrete literature review is crucial for future therapeutics. This review provides a comprehensive overview of the effective role of H2S in respiratory diseases and its metabolism processes in the lung.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Current Perspective of Hydrogen Sulfide as a Novel Gaseous Modulator of Oxidative Stress in Glaucoma

Yuan Feng et al.

Summary: Glaucoma is a group of diseases characterized by the progressive loss of retinal ganglion cells and their axons, with oxidative stress believed to be a main risk factor in neurodegeneration. The gas signaling molecule hydrogen sulfide (H2S) plays a pivotal role in modulating oxidative stress in glaucoma by regulating different pathways in vivo. This review summarizes the distribution and properties of H2S in the eye, emphasizing its role in modulating oxidative stress in glaucoma.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Hydrogen Sulfide Reduces Ischemia and Reperfusion Injury in Neuronal Cells in a Dose- and Time-Dependent Manner

Stefanie Scheid et al.

Summary: Experimental results confirm that inhaled H2S at appropriate concentrations can exert neuroprotective effects in rat retinal ischemia-reperfusion injury, reducing cell apoptosis and inflammation. H2S treatment modulates NF-kappa B activation and is expected to alleviate inflammation after retinal injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

The H2S-Donor Erucin Exhibits Protective Effects against Vascular Inflammation in Human Endothelial and Smooth Muscle Cells

Alma Martelli et al.

Summary: The study demonstrates that erucin can effectively prevent high glucose-induced endothelial dysfunction and inflammation by inhibiting ROS and inflammatory markers levels, protecting vascular cell integrity, and also has a certain inhibitory effect on the increase in vascular permeability.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Organic Isothiocyanates as Hydrogen Sulfide Donors

Alma Martelli et al.

ANTIOXIDANTS & REDOX SIGNALING (2020)

Article Pharmacology & Pharmacy

Role of hydrogen sulfide in cardiovascular ageing

Lara Testai et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Chemistry, Medicinal

Structural hybridization as a facile approach to new drug candidates

Halmuthur M. Sampath Kumar et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Pharmacology & Pharmacy

Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma

Giuseppe Ercolano et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biochemical Research Methods

First Examples of H2S-Releasing Glycoconjugates: Stereoselective Synthesis and Anticancer Activities

Serena Fortunato et al.

BIOCONJUGATE CHEMISTRY (2019)

Article Chemistry, Medicinal

1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors

Beatrice Severino et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Topical treatment of glaucoma: established and emerging pharmacology

Mark S. Dikopf et al.

EXPERT OPINION ON PHARMACOTHERAPY (2017)

Review Medicine, General & Internal

Glaucoma

Jost B. Jonas et al.

LANCET (2017)

Article Ophthalmology

Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo

Hanhan Liu et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Article Chemistry, Medicinal

Conformational control in structure-based drug design

Yajun Zheng et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Article Medicine, General & Internal

Primary open-angle glaucoma

Robert N. Weinreb et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Biochemistry & Molecular Biology

Production and Physiological Effects of Hydrogen Sulfide

Hideo Kimura

ANTIOXIDANTS & REDOX SIGNALING (2014)

Review Medicine, General & Internal

The Pathophysiology and Treatment of Glaucoma A Review

Robert N. Weinreb et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Chemistry, Medicinal

Arylthioamides as H2S Donors: L-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo

Alma Martelli et al.

ACS MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

New prostaglandin derivative for glaucoma treatment

Elena Perrino et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Review Pharmacology & Pharmacy

Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics

Eliisa Mannermaa et al.

ADVANCED DRUG DELIVERY REVIEWS (2006)

Article Biochemistry & Molecular Biology

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

Renata C. O. Zanardo et al.

FASEB JOURNAL (2006)

Article Biochemistry & Molecular Biology

Two's company, three's a crowd:: can H2S be the third endogenous gaseous transmitter?

R Wang

FASEB JOURNAL (2002)

Article Ophthalmology

The definition and classification of glaucoma in prevalence surveys

PJ Foster et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2002)

Article Pharmacology & Pharmacy

Biopharmaceutical considerations in topical ocular drug delivery

NM Davies

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)